IsoPlexis Corporation provides Preliminary revenue guidance for the full year ended December 31, 2022. Total revenue for the full year ended December 31, 2022 is expected to be in the range of $16.6 to $16.8 million, representing a decrease of approximately 3% to 4% compared to $17.3 million for the full year ended December 31, 2021.
IsoPlexis Corporation
Equities
ISO
US4650051067
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+5.85% | 32.95B | |
+20.16% | 8.09B | |
+30.81% | 4B | |
-25.95% | 3.09B | |
-19.96% | 1.39B | |
-31.87% | 1.19B | |
+8.02% | 966M | |
-35.73% | 933M | |
-25.74% | 834M |